IDH1 and glioblastoma: Furthermore, introduction of mutant IDH1 in glioblastoma cells and transformed astrocytes inhibited cell proliferation, reduced tumor growth, and improved mouse survival [43–45] (Tiburcio et al., manuscript in preparation).